Patient-centric trials in a post-pandemic world

COVID-19 is fueling the innovation and modernization of clinical trials, driving the use of technology to bring the trial to the patient. Given that cancer patients are among the most vulnerable, sponsors and investigators managing oncology studies have embraced virtual and hybrid tools to keep patients safe and trials moving forward.  

Download this insight brief to learn how to incorporate virtual approaches into the design and delivery of oncology clinical trials to lower overall study risks and increase patient engagement.  

You will learn: 
• Lessons learned from adapting ongoing oncology trials during the pandemic
• Criteria to identify which trials are suitable for virtual or hybrid methods
• Innovative and flexible approaches that improve the patient experience

Having a team with experience running virtual oncology clinical trials is critical to the success of your decentralized clinical program. Contact us to learn how our dedicated oncology team can help you choose the best approach.